NCI-60 Human Tumor Cell Lines Screen (NCI-60)
Owner/Developer: National Cancer Institute (NCI)
| Country: | United States of America |
|---|---|
| Languages: | English |
| Url: | https://dtp.cancer.gov/discovery_development/nci-60/ |
| Description: |
The NCI-60 Human Tumor Cell Lines Screen has served the global cancer research community for >20 years. The screen was implemented in fully operational form in 1990 and utilizes 60 different human tumor cell lines to identify and characterize novel compounds with growth inhibition or killing of tumor cell lines. It is designed to screen up to 3,000 small molecules (synthetic or purified natural products) per year for potential anticancer activity. The operation of this screen utilizes 60 different human tumor cell lines, representing leukemia, melanoma and cancers of the lung, colon, brain, ovary, breast, prostate, and kidney cancers. |
| Category: | Information System |
| Channel: | Website |
| Audience: | Researchers |
| User access: | Open access |
| Updating frequency: | Infrequently updated |
| Relevance: | Replacement - Reduction |
| Purpose: | Documentation and information |
| Technology/Tools: | Alternative test methods (in vitro) |
Did you find what you were looking for?
Yes, I found it! No, I did not!Thanks for your feedback! Please note that we cannot respond unless you supply your email address.
What are you looking for?
Please give us your feedback so we can improve the information on the page. Thank you in advance for your help. Please add your email address if you would like a reply.
Please contact us by email if you have any questions.